Sarcoma  >>  Neulasta (pegfilgrastim)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

10 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Neulasta (pegfilgrastim) / Roche
NCT00003955: Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Metastatic Rhabdomyosarcoma or Sarcoma

Completed
2
77
Europe, Canada, US, RoW
dactinomycin, filgrastim, pegfilgrastim, sargramostim, cyclophosphamide, irinotecan hydrochloride, vincristine sulfate, radiation therapy
Children's Oncology Group, National Cancer Institute (NCI)
Sarcoma
01/05
10/09
NCT00101127: Docetaxel, Gemcitabine, and Filgrastim (G-CSF) or Pegfilgrastim in Treating Patients With Advanced, Persistent, or Recurrent Uterine Leiomyosarcoma

Completed
2
US
filgrastim, pegfilgrastim, docetaxel, gemcitabine hydrochloride
Gynecologic Oncology Group, National Cancer Institute (NCI)
Sarcoma
07/06
 
NCT00035620: Pegfilgrastim as Support to Pediatric Sarcoma Patients Receiving Chemotherapy

Completed
2
44
US
pegfilgrastim, filgrastim
Amgen
Sarcoma, Neutropenia
01/07
04/07
NCT00031629: Combination Chemotherapy and Filgrastim or Pegfilgrastim in Treating Patients With Recurrent or Persistent Cancer of the Uterus

Completed
2
51
US
Docetaxel, Docecad, RP56976, Taxotere, Taxotere Injection Concentrate, Filgrastim, Filgrastim XM02, Filgrastim-sndz, G-CSF, Neupogen, r-metHuG-CSF, Recombinant Methionyl Human Granulocyte Colony Stimulating Factor, rG-CSF, Tbo-filgrastim, Tevagrastim, Zarxio, Gemcitabine Hydrochloride, dFdCyd, Difluorodeoxycytidine Hydrochloride, Gemzar, LY-188011, LY188011, Pegfilgrastim, Filgrastim SD-01, filgrastim-SD/01, HSP-130, Neulasta, Neulastim, Pegfilgrastim Biosimilar HSP-130, SD-01, SD-01 sustained duration G-CSF
Gynecologic Oncology Group, National Cancer Institute (NCI)
Recurrent Uterine Corpus Sarcoma, Uterine Corpus Leiomyosarcoma
07/07
 
NCT00068393: Doxorubicin and Gemcitabine in Treating Patients With Locally Recurrent or Metastatic Unresectable Renal Cell Carcinoma

Completed
2
39
US
Doxorubicin, Adriamycin, Rubex, Gemcitabine, G-CSF (granulocyte-colony stimulating factor), Neupogen, Filgrastim, Neulasta, pegfilgrastim
Eastern Cooperative Oncology Group, National Cancer Institute (NCI)
Metastatic Renal Cell Carcinoma, Renal Cell Carcinoma With Sarcomatoid Features
06/09
05/11
NCT00073983: Gemcitabine and Docetaxel in Treating Patients With Recurrent Osteosarcoma (Closed to Accrual as of 12/21/06) or Ewing's Sarcoma or Unresectable or Locally Recurrent Chondrosarcoma

Completed
2
54
US
filgrastim, pegfilgrastim, docetaxel, gemcitabine hydrochloride, microarray analysis, laboratory biomarker analysis, pharmacokinetic study
Sarcoma Alliance for Research through Collaboration
Sarcoma
01/10
12/10
NCT01313884: Cyclophosphamide, Doxorubicin, Vincristine w/ Irinotecan and Temozolomide in Ewings Sarcoma

Terminated
2
3
US
Irinotecan, Camptosar, Campto, Vincristine, Oncovin, leurocristine, Temozolomide, Temodar, Temodal, Doxorubicin, Adriamycin, hydroxydaunorubicin, Cytoxan, Cyclophosphamide, Endoxan, Neosar, Procytox, Revimmune, cytophosphane, Pegfilgrastim, Neulasta
Stanford University, Amgen
Bone Cancer, Ewing's Sarcoma
07/14
07/14
RMS13, NCT01871766: Risk-Adapted Focal Proton Beam Radiation and/or Surgery in Patients With Low, Intermediate and High Risk Rhabdomyosarcoma Receiving Standard or Intensified Chemotherapy

Active, not recruiting
2
98
US
Vincristine, Oncovin®, Dactinomycin, Actinomycin-D, Cosmegen®, Cyclophosphamide, Cytoxan(R), Surgical Resection, Surgery, Radiation, Proton Beam Radiation, External Beam Radiation, Brachytherapy, Bevacizumab, rhuMab, VEGF, Avastin®, Sorafenib, Nexavar®, Myeloid Growth Factor, G-CSF, Filgrastim, Pegfilgrastim, Lymph Node Sampling, Irinotecan, Camptosar ®, Ifosfamide, Ifex ®, Etoposide, VP-16, Vepesid®, Etoposide Phosphate, Etopophos®, Doxorubicin, Adriamycin®, Dexrazoxane, Zinecard, ^1^1C-methionine, Contrast Media
St. Jude Children's Research Hospital
Rhabdomyosarcoma
07/25
06/30
GemTax, NCT01879085: Study of Vorinostat in Combination With Gemcitabine and Docetaxel in Advanced Sarcoma

Completed
1b/2
37
US
Docetaxel, Taxotere, Gemcitabine, Gemzar, Vorinostat, Zolinza, Pegfilgrastim, Neulasta
Melissa Burgess, MD, Merck Sharp & Dohme LLC
Sarcoma
04/21
04/21
TINKS, NCT05634369: A Multi-Institution Study of TGFβ Imprinted, Ex Vivo Expanded Universal Donor NK Cell Infusions as Adoptive Immunotherapy in Combination With Gemcitabine and Docetaxel in Patients With Relapsed or Refractory Pediatric Bone and Soft Tissue

Recruiting
1/2
50
US
GEM/DOX + TGFBi expanded NK cells, Docetaxel, Dexamethasone, Pegfilgrastim, Gemcitabine
Nationwide Children's Hospital, National Pediatric Cancer Foundation
Pediatric Sarcoma, Refractory, Pediatric Sarcoma, Relapsed
12/26
12/27

Download Options